跳转到主要内容
1496 个结果

对被忽视的热带病治疗的审批提供支持

In this video, Dr. Mark Sullivan, Managing Director of Medicines Development for Global Health, explains how Certara’s model-informed drug development expertise was used to support developing moxidectin as a treatment for onchocerciasis “river blindness.” Transcript The role that Certara has played has really been a as an as a integral part of our drug development … Continued

https://www.certara.com.cn/video/supporting-the-approval-of-a-treatment-for-a-neglected-tropical-disease/

Certara 将于 2024 年 5 月 7 日发布 2024 年第一季度财报并参加 BofA Securities Healthcare Conference

PRINCETON, N.J.— 2024 年 4 月 9 日– Certara, Inc. (纳斯达克股票代码:CERT), a global leader in biosimulation, today announced that it will release financial results for the first quarter of 2024 after the market close on Tuesday, May 7th, 2024. Company management will host a conference call to discuss financial results at 5:00PM ET. Investors interested in listening … Continued

https://www.certara.com.cn/pressrelease/certara-to-report-first-quarter-2024-financial-results-on-may-7th-2024-and-participate-in-the-bofa-securities-healthcare-conference/

Oil and Gas

The oil and gas industry has been known for its complexity and challenging operating environments, with installations all over the world, in complicated and remote locations. According to a recent Ernst & Young survey, 92% of oil and gas companies around the world are investing in AI or plan to do so in the next … Continued

https://www.certara.com.cn/oil-and-gas/

用于预测 OATP1B DDI 的内源性生物标志物

This blog reviews the role of the endogenous biomarker, CP-1, for assessing OATP1B transporter-mediated drug-drug interactions and their clinical implications.

https://www.certara.com.cn/blog/an-endogenous-biomarker-for-predicting-oatp1b-ddis/

是什么促使对 SEND 数据集服务的需求增加?

Gain an understanding of CDISC SEND dataset creation challenges impacting the biopharma industry, and how these factors could delay regulatory submissions and strategic initiatives.

https://www.certara.com.cn/blog/whats-driving-the-increased-demand-for-send-dataset-services/

闭环:如何改进您的设计-合成-测试-分析周期的管理

Scientists in drug discovery often spend excessive time managing research data instead of concentrating on identifying the most promising compounds for new drugs. The right technology streamlines the drug discovery process, providing a seamless workflow for data-driven design, analysis, and research tracking of small molecules. In this webinar, experts from Certara and Chemaxon will guide … Continued

https://www.certara.com.cn/on-demand-webinar/closing-the-loop-how-to-improve-the-management-of-your-design-make-test-analyze-cycle/

Certara.AI

Transcript: Did you know that eighty percent of life sciences data is unstructured? This data is messy, difficult to search, often resides in silos. Having unstructured data means that you could be missing valuable insights that can inform prioritizing new molecules for designing, executing, or submitting clinical trials. The proliferation of powerful AI models such … Continued

https://www.certara.com.cn/video/certara-ai/

Certara Talks: PHUSE 2024 Recap

In this episode of Certara Talks, Jeff Abolafia, Kristin Kelly, and Julie Ann Hood recap their fantastic presentations from PHUSE US Connect earlier this month. The team covered inspirational and innovative topics, and Julie Ann and Jeffrey won Best in Stream for their presentations ‘Sowing Seeds of Inspiration: Letters to a Pre-Scientist’ and ‘Future Clinical … Continued

https://www.certara.com.cn/video/certara-talks-phuse-2024-recap/
4 页,共 150 页

沪ICP备2022021526号

Powered by Translations.com GlobalLink OneLink Software